Namzaric (memantine hydrochloride and donepezil hydrochloride)

The drug Namzaric of the pharmaceutical company Actavis, intended for treatment of Alzheimer’s disease, has become available in the USA. The drug was approved by the FDA back in December 2014 for the treatment of patients with Alzheimer’s disease, if their condition stabilized after taking memantine hydrochloride and donepezil hydrochloride. The preparation Namzarik is a …